DarioHealth
DRIO
46 hedge funds and large institutions have $38.1M invested in DarioHealth in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 5 closing their positions.
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
0% more funds holding
Funds holding: 46 → 46 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.2% less ownership
Funds ownership: 1.99% → 1.79% (-0.2%)
2% less capital invested
Capital invested by funds: $38.9M → $38.1M (-$768K)
60% less call options, than puts
Call options by funds: $63K | Put options by funds: $156K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Shay Capital
New York
|
+$491K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$452K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$214K |
| 4 |
Renaissance Technologies
New York
|
+$197K |
| 5 |
LPL Financial
San Diego,
California
|
+$186K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWAM
Appian Way Asset Management
New York
|
-$595K |
| 2 |
Millennium Management
New York
|
-$539K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$237K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$160K |
| 5 |
YDMI
Y.D. More Investments
Ramat Gan,
Israel
|
-$148K |
DRIO Hedge Fund Activity: Q1 2023 in Review
46 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q1 2023, worth a combined $38.1M — down 2% from $38.9M a quarter earlier.
Fund positioning in DRIO was balanced in Q1 2023: 5 funds opened new positions, 5 closed out, 13 added to existing stakes and 10 trimmed.
The largest buyer was Shay Capital, opening a new position worth an estimated $491K. The largest seller was Appian Way Asset Management, cutting an estimated $595K.
- 46 institutional investors held DarioHealth (DRIO) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $38.1M of DarioHealth stock for Q1 2023, down 2% quarter-over-quarter.
- 5 funds opened new DarioHealth positions in Q1 2023 and 5 closed out, a net change of 0 holders.
- The largest DarioHealth buyer in Q1 2023 was Shay Capital, an estimated $491K added.
- The largest DarioHealth seller in Q1 2023 was Appian Way Asset Management, an estimated $595K sold.
Based on aggregated 13F filings for Q1 2023.